{"corpus_id":92628053,"paper_sha":"b6f238035b40fed9d8966e84f3b50dcf1875a728","doi":"10.1002/2211-5463.12601","arxiv_id":null,"pmid":30984540,"pmcid":"6443865","mag_id":2912676825,"dblp_id":null,"acl_id":null,"title":"An autophagy‐related long non‐coding RNA signature for glioma","year":2019,"publication_date":"2019-03-05","venue":"FEBS Open Bio","journal":{"name":"FEBS Open Bio","pages":"653 - 667","volume":"9"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Biology","Medicine"],"reference_count":36,"citation_count":97,"influential_citation_count":2,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Autophagy","mj":false,"qs":[{"q":"genetics","mj":true,"ui":"Q000235"}],"ui":"D001343"},{"d":"China","mj":false,"ui":"D002681"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Gene Expression Regulation, Neoplastic","mj":false,"ui":"D015972"},{"d":"Glioma","mj":false,"qs":[{"q":"diagnosis","mj":false,"ui":"Q000175"},{"q":"genetics","mj":true,"ui":"Q000235"}],"ui":"D005910"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"MicroRNAs","mj":false,"qs":[{"q":"genetics","mj":false,"ui":"Q000235"}],"ui":"D035683"},{"d":"Prognosis","mj":false,"ui":"D011379"},{"d":"RNA, Long Noncoding","mj":false,"qs":[{"q":"analysis","mj":true,"ui":"Q000032"}],"ui":"D062085"}],"chemicals":[{"n":"MicroRNAs","ui":"D035683","reg":"0"},{"n":"RNA, Long Noncoding","ui":"D062085","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/2211-5463.12601","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/b6f238035b40fed9d8966e84f3b50dcf1875a728","s2_open_access_license":"CCBY","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Glioma is one of the most common types of malignant primary central nervous system tumor, and prognosis for this disease is poor. As autophagic drugs have been reported to induce glioma cell death, we investigated the potential prognostic role of autophagy‐associated long non‐coding RNA (lncRNA) in glioma patients. In this study, we obtained 879 lncRNAs and 216 autophagy genes from the Chinese Glioma Genome Atlas microarray, and found that 402 lncRNAs are correlated with the autophagy genes. Subsequently, 10 autophagy‐associated lncRNAs with prognostic value (PCBP1‐AS1, TP53TG1, DHRS4‐AS1, ZNF674‐AS1, GABPB1‐AS1, DDX11‐AS1, SBF2‐AS1, MIR4453HG, MAPKAPK5‐AS1 and COX10‐AS1) were identified in glioma patients using multivariate Cox regression analyses. A prognostic signature was then established based on these prognostic lncRNAs, dividing patients into low‐risk and high‐risk groups. The overall survival time was shorter in the high‐risk group than that in the low‐risk group [hazard ratio (HR) = 5.307, 95% CI: 4.195–8.305; P < 0.0001]. Gene set enrichment analysis revealed that the gene sets were significantly enriched in cancer‐related pathways, including interleukin (IL) 6/Janus kinase/signal transducer and activator of transcription (STAT) 3 signaling, tumor necrosis factor α signaling via nuclear factor κB, IL2/STAT5 signaling, the p53 pathway and the KRAS signaling pathway. The Cancer Genome Atlas dataset was used to validate that high‐risk patients have worse survival outcomes than low‐risk patients (HR = 1.544, 95% CI: 1.110–2.231; P = 0.031). In summary, our signature of 10 autophagy‐related lncRNAs has prognostic potential for glioma, and these autophagy‐related lncRNAs may play a key role in glioma biology.","claims":[{"public_id":"cl_c91d9ba636f41cf791b3cc7826b0e2f4","status":"active","text":"High-risk patients have significantly shorter overall survival than low-risk patients in the discovery cohort.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_c91d9ba636f41cf791b3cc7826b0e2f4"},{"public_id":"cl_8050370b13e971630df62e7a808eeb95","status":"active","text":"Ten autophagy-related lncRNAs form a prognostic signature that separates glioma patients into low-risk and high-risk groups.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_8050370b13e971630df62e7a808eeb95"},{"public_id":"cl_fd4601adfb2462313eecc37b9881d53e","status":"active","text":"The prognostic separation is validated in The Cancer Genome Atlas dataset, where high-risk patients again have worse survival outcomes.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_fd4601adfb2462313eecc37b9881d53e"},{"public_id":"cl_2b9d6f15690da0aa47cc571fa815d0ef","status":"active","text":"The signature-associated gene sets are enriched in cancer-related pathways, including IL6/STAT3 signaling, TNFα signaling via NF-κB, IL2/STAT5 signaling, the p53 pathway, and the KRAS signaling pathway.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_2b9d6f15690da0aa47cc571fa815d0ef"}],"concepts":[{"public_id":"co_0d87d4b187ba290700690b9d0b2c9492","status":"active","name":"high-risk group","description":"Patients classified by the signature as having higher predicted survival risk.","types":["risk group"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_0d87d4b187ba290700690b9d0b2c9492"},{"public_id":"co_11d21bf30caa9955391583bc83ebe674","status":"active","name":"autophagy-related lncRNA signature","description":"A prognostic model built from long non-coding RNAs associated with autophagy genes in glioma.","types":["prognostic model","biomarker signature"],"aliases":["autophagy-associated lncRNA signature"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_11d21bf30caa9955391583bc83ebe674"},{"public_id":"co_24e4542cbacc1ed2ade664a777f5c909","status":"active","name":"The Cancer Genome Atlas dataset","description":"An external genomic dataset used here to validate the prognostic signature.","types":["dataset","validation cohort"],"aliases":["TCGA dataset","TCGA"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_24e4542cbacc1ed2ade664a777f5c909"},{"public_id":"co_73e5228db771572a8553f51a54ecec89","status":"active","name":"overall survival time","description":"The duration of survival used as the outcome measure in the prognostic analysis.","types":["outcome"],"aliases":["overall survival","OS"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_73e5228db771572a8553f51a54ecec89"},{"public_id":"co_758c8213ba070d9fa673394fdc4a90f2","status":"active","name":"low-risk group","description":"Patients classified by the signature as having lower predicted survival risk.","types":["risk group"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_758c8213ba070d9fa673394fdc4a90f2"},{"public_id":"co_9b3875384b530c7ce6947a6262f2d1da","status":"active","name":"glioma","description":"A malignant primary central nervous system tumor analyzed in this study.","types":["cancer","disease"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_9b3875384b530c7ce6947a6262f2d1da"},{"public_id":"co_ab3a37b1755a920494c4fea25e1ae0f9","status":"active","name":"glioma patients","description":"Individuals with glioma whose transcriptomic data and survival outcomes were analyzed.","types":["patient population"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ab3a37b1755a920494c4fea25e1ae0f9"},{"public_id":"co_c223f8e238a785399409748d9048b0ab","status":"active","name":"IL6/STAT3 signaling","description":"A cancer-related signaling pathway involving interleukin 6 and STAT3.","types":["pathway"],"aliases":["IL 6/Janus kinase/signal transducer and activator of transcription 3 signaling"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c223f8e238a785399409748d9048b0ab"},{"public_id":"co_c33655b785239c719a4728d8c56c4013","status":"active","name":"prognostic signature","description":"A composite risk model used to stratify patients by survival risk.","types":["prediction model","biomarker signature"],"aliases":["risk signature"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c33655b785239c719a4728d8c56c4013"},{"public_id":"co_c6106371a52fe038eacd86bf1919c6a1","status":"active","name":"autophagy-associated long non-coding RNA","description":"Long non-coding RNA molecules correlated with autophagy genes in the glioma dataset.","types":["molecular marker","RNA"],"aliases":["autophagy-related lncRNA","autophagy-associated lncRNA","lncRNA"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c6106371a52fe038eacd86bf1919c6a1"},{"public_id":"co_d0a368d06e3328ef02f0beaf4f0f007a","status":"active","name":"gene set enrichment analysis","description":"A computational method used to identify pathways enriched in the signature-related genes.","types":["analysis method"],"aliases":["GSEA"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d0a368d06e3328ef02f0beaf4f0f007a"},{"public_id":"co_f8eac3328322896163f26ae65b07abb9","status":"active","name":"KRAS signaling pathway","description":"A signaling pathway centered on KRAS-related oncogenic activity.","types":["pathway"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f8eac3328322896163f26ae65b07abb9"}],"external_ids":{"DOI":"10.1002/2211-5463.12601","ArXiv":null,"PubMed":30984540,"PubMedCentral":"6443865","MAG":2912676825,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/2211-5463.12601","landing_url":"https://www.semanticscholar.org/paper/b6f238035b40fed9d8966e84f3b50dcf1875a728","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBY","status":"GOLD","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":637568,"paper_uid":"7055fde5-fe03-43a3-a182-3edfc97e3db2","canonical_identity":{"paper_id":637568,"paper_uid":"7055fde5-fe03-43a3-a182-3edfc97e3db2","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/92628053"}